Clearbridge Health Ltd. (SG:1H3) has released an update.
Clearbridge Health Ltd. has announced a strategic re-allocation of S$2,695,000 from its net proceeds originally intended for business expansion through various avenues in Asia to general working capital purposes. This decision is aimed at bolstering the Group’s operations amidst its current cash flow and operating environment. The company has reassured that this re-allocation aligns with the shareholders’ interests and will continue to provide updates on the proceeds’ utilization.
For further insights into SG:1H3 stock, check out TipRanks’ Stock Analysis page.
